U.S. markets closed

Roche Holding AG (RHHBY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
46.07-0.75 (-1.60%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close46.82
Open46.36
BidN/A x N/A
AskN/A x N/A
Day's Range45.88 - 46.40
52 Week Range39.72 - 51.05
Volume1,824,467
Avg. Volume1,073,485
Market Cap323.695B
Beta (5Y Monthly)0.27
PE Ratio (TTM)20.87
EPS (TTM)2.21
Earnings DateN/A
Forward Dividend & Yield1.22 (2.61%)
Ex-Dividend DateMar 18, 2021
1y Target Est52.44
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ROCHE HOLDINGS AG
    Analyst Report: Roche Holding AGRoche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 60% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
    Rating
    Fair Value
    Economic Moat
    5 days agoMorningstar
View more